Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zipper therapy breakthrough: new combo may boost recovery in rare brain disease

NCT ID NCT07420296

Recruiting now Disease control Sponsor: Tianjin Medical University General Hospital Source: ClinicalTrials.gov ↗

First seen Feb 22, 2026 · Last updated May 23, 2026 · Updated 13 times

Summary

This study tests a new treatment called 'Modified Zipper Therapy' for people with a rare autoimmune disease called NMOSD. The therapy combines standard treatments with a drug that blocks part of the immune system to help patients recover better from sudden attacks. About 198 adults with active NMOSD will be randomly assigned to get either the new combo or standard care, and researchers will compare how well their vision and movement improve over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tianjin Medical University General Hospital, Department of Neurology

    RECRUITING

    Tianjin, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)